• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·S. Africa·Consumer Cyclical·BRN.JO
Share

Brimstone Investment Corporation Limited Stocks

ZAC 573Last Updated 21.10.2026

Issuer Rating

3/7
Performance

Favourable

Risk

High

Recommendation

Sell

Market Cap

ZAC 799560.47304

ZAC 573
Key Takeaways

Risk factor

Very high price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Undervalued vs peers

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Brimstone Investment Corporation Limited, an investment holding firm based in Cape Town, South Africa, was established in 1995. The company maintains a diversified portfolio with interests across various sectors, including food, healthcare, property, Black Economic Empowerment (B-BBEE) initiatives, and enterprise development. Its operational footprint extends beyond South Africa to Australia, Europe, and other international markets. Brimstone's activities encompass commercial fishing for species like cape hakes and king prawns, as well as the processing and distribution of frozen and chilled seafood. Additionally, it operates retail chains such as C2 and Carducci, markets food products under brands like Ladismith Cheese, and delivers advanced solutions to healthcare providers and clinicians throughout Sub-Saharan Africa.

Company Valuation

Undervalued
6/7

From both historical and forecast perspectives, the stock is underpriced compared to similar stocks. Specifically, the stock is 'expensive' on P/E, overvalued on EV/EBITD

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

22.10.2026 19:34

A merger between Tesla and SpaceX could net Musk more than $110 billion. What are the risks for shareholders?

22.10.2026 18:52

The sell-off in U.S. stocks continued: The Nasdaq fell nearly 2%. What should investors do?

22.10.2026 18:02

"Demand Is Through the Roof": Huang Identified Obstacles to Neocloud's Growth Amid Its Sell-Off

22.10.2026 17:35

Motley Fool: Six next-generation tech stocks not to forget amid the Anthropic IPO

22.10.2026 17:05

Investors seeking safe havens have driven the valuations of "toothpaste" stocks above those of the tech sector

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026